Online first
Clinical vignette
Published online: 2024-11-07
Inadvertent implantation of conduction system pacing lead into left ventricle via patent foramen ovale in dual-chamber pacemaker
Pubmed: 39535945
Abstract
Not available
References
- van Stipdonk A, Wijers S, Meine M, et al. ECG patterns in cardiac resynchronization therapy. J Atr Fibrillation. 2015; 7(6): 1214.
- Burri H, Jastrzebski M, Cano Ó, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace. 2023; 25(4): 1208–1236.
- Contractor T, Co ML, Cooper JM, et al. Management of inadvertent lead placement in the left ventricle via a patent foramen ovale: A multidisciplinary approach. HeartRhythm Case Rep. 2020; 6(2): 89–93.
- Wu H, Jiang L, Shen J. Recording an isoelectric interval as an endpoint of left bundle branch pacing with continuous paced intracardiac electrogram monitoring. Kardiol Pol. 2022; 80(6): 664–671.
- Araszkiewicz A, Bartuś S, Demkow M, et al. Interventional closure of patent foramen ovale (PFO) in the prevention of thromboembolic events. Opinion of experts from the Association of Cardiovascular Interventions and the Section of Congenital Heart Defects in Adolescents and Adults of the ish Cardiac Society [in ish]. Kardiol Pol. 2019; 77(Supp. III): 90–104.
